National Cancer Institute’s latest focus: Breast cancer genetics in black women

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

[On July 2016,] the National Cancer Institute is turning its focus on studying breast cancer genetics in black women. It would be one of the largest studies to ever do so.

“There have been great advances in the treatment of breast cancer in the general population, the problem is the African American women have not benefited from all the advances in cancer therapy,” said Dr. Barry Ramo.

The NCI study will not be evaluating new patients. Instead, the NCI will be analyzing already [compiled] data from close to 20 different prior studies involving more than 20,000 women.


Dr. Ramo said researchers will try to glean new information from these studies to develop better and more efficient cancer therapies and treatments.

The NCI said while we have seen breast cancer survival rates climb, black women are still more likely to die from the disease, and are twice as likely to be diagnosed with a more aggressive sub-type of the cancer than white women. The NCI says it’s unclear why this disparity exists.

Read full, original post: Study to examine breast cancer genetics in black women

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend